OncoZenge AB insider transactionsStockholm
LEI 2549003980RBCR6NIF38 · XSTO · SE · Business ID 559261-9968
Get alerts for OncoZenge AB
12-month buy/sell summary
SEK 593,894.70 boughtNo sales
Open-market buys: 3Sales: 0Share awards: 2
Recent insider sentiment
Net buying — last 90 days
SEK 196,400.00 boughtNo sales
Share-award batches are excluded from this read — they’re compensation, not conviction.
2
Open-market buys (90d)
0
Sales (90d)
2
Share awards (90d)
3
Active insiders (90d)
Transactions
| Date | Person | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 23.09.2026 | Per Daniel Ehrenstråhle — Board member | New shares (subscription) | 100,000 | SEK 3.00 | SEK 300,000.00 | ↗ |
| 18.09.2026 | Paul Murtagh — Board member | New shares (subscription) | 118,500 | SEK 3.00 | SEK 355,500.00 | ↗ |
| 18.09.2026 | Stian Kildal — CEO | New shares (subscription) | 375,000 | SEK 3.00 | SEK 1,125,000.00 | ↗ |
| 06.09.2026 | Per Daniel Ehrenstråhle — Board member | Share award | 1,000,000 | — | Share award 1,000,000 units | ↗ |
| 06.09.2026 | Stian Kildal — CEO | Share award | 1,000,000 | — | Share award 1,000,000 units | ↗ |
| 28.08.2026 | Paul Murtagh — Board member | Bought — open marketAcquisition | 20,000 | SEK 5.05 | SEK 101,000.00 | ↗ |
| 27.08.2026 | Paul Murtagh — Board member | Bought — open marketAcquisition | 18,000 | SEK 5.30 | SEK 95,400.00 | ↗ |
| 28.11.2025 | Stian Kildal — CEO | Bought — open marketAcquisition | 74,999 | SEK 5.30 | SEK 397,494.70 | ↗ |
| 09.09.2025 | Stian Kildal — CEO | Bought — open marketAcquisition | 25,000 | SEK 6.30 | SEK 157,500.00 | ↗ |
| 26.08.2025 | Stian Kildal — CEO | Bought — open marketAcquisition | 25,001 | SEK 6.94 | SEK 173,506.94 | ↗ |
Active insiders (90d)
Stian Kildal
CEO
1,375,000 shares
2 filings
Per Daniel Ehrenstråhle
Board member
1,100,000 shares
2 filings
Paul Murtagh
Board member
156,500 shares
3 filings